New Possibilities for Maintenance Therapy in AML
AML Case Challenge
Click the "View Activity" button to view this activity.View Activity
CME/CE is no longer available for this activity
• Discuss predictive factors that contribute to patient relapse in acute myeloid leukemia (AML).
• Analyze recent clinical trial data of new and emerging therapies for AML in the maintenance setting.
• Formulate collaborative strategies and shared decision-making (SDM) practices to ensure patient engagement in treatment decisions regarding AML care.
Sponsored by PennState College of Medicine and the Academy for Continued Healthcare Learning (ACHL).
Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Penn State College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.